Meltem Karslıoğlu

Dr. Meltem Karslıoğlu


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2024 in Anatolian Current Medical Journal
Verified
Journal Article
Open access
PDF file
MKMeltem Karslıoğlu
Meltem Karslıoğlu
MYMerve Olpak Yilmaz
Merve Olpak Yilmaz
Aims: This study investigates the frequency and associated factors of urinary tract infections (UTIs) in patients with diabetes mellitus (DM). Methods: This retrospective chart review focused on patients with diabetes mellitus. Data collection involved demographic details, DM diagnosis, comorbidities such as hypertension, hyperlipidemia, and coronary artery disease, along with medication usage. Laboratory values including blood glucose and HbA1c levels were also analyzed. The primary outcome of interest was the diagnosis of UTI, identified from clinical records. Results: 173 DM patients were included in the study. These patients were divided into two groups according to the presence of UTI: 52 patients in the UTI group and 121 patients in the non-UTI group. The incidence of UTI was significantly higher in women (37.9%) compared to men (10.2%). No significant differences were observed between the groups in terms of age, presence of hypertension, hyperlipidemia, or coronary artery disease. Interestingly, the usage of SGLT-2 inhibitors was significantly higher in the UTI group compared to the non-UTI group (26.8% vs. 14%, p=0.043). No significant differences were found in other medication usage or in the levels of glucose and HbA1c between the groups. Conclusion: The study highlights the increased risk of UTIs in DM patients, particularly among women and those using SGLT-2 inhibitors. These findings suggest the need for careful monitoring and tailored approaches in managing UTIs in DM patients, considering gender and specific DM treatments.

25 September 2025 in Infectious Diseases and Clinical Microbiology
Verified
Journal Article
Open access
EAElif SARGIN ALTUNOK
Elif SARGIN ALTUNOK
ŞKŞiran Keske
Şiran Keske
ABAyse Batirel
Ayse Batirel
HBHuseyin Bilgin
Huseyin Bilgin
EGEzgi Gülten
Ezgi Gülten
Onder ErgonulOnder Ergonul
Onder Ergonul
Healthcare-associated infections (HAIs) are common yet largely preventable through adherence to evidence-based guidelines. In 2005, Türkiye implemented a national infection control program, which led to significant reductions in HAI rates, including a 50% decrease in central line-associated bloodstream infections (CLABSIs) between 2008 and 2017. This result was in parallel with data from

1 January 2024 in Journal of Clinical and Analytical Medicine
Verified
Journal Article
Closed access
MKMeltem Karslıoğlu
Meltem Karslıoğlu
ADAydın Deveci
Aydın Deveci

21 March 2025 in Journal of Health Sciences and Medicine
Verified
Journal Article
Open access
PDF file
MKMeltem Karslıoğlu
Meltem Karslıoğlu
Aims: Infections of the urinary tract, or UTIs, are a major public health issue that affects patient prospects especially in cases of nosocomial infections. Albeit quite a bit of research has been conducted there are still information gaps especially with respect to strategies for its prevention as well as the impact of environmental and social determinants. In this paper, we target to conduct a review of bibliometrics of UTI researches from 2004 to 2023, including number and types of publications, prominent scholars, journals, organizations, and specific areas of interest for publication purposes. Methods: Data for this bibliometric analysis were retrieved from the Web of Science Core Collection, covering articles published between January 1, 2004, and December 31, 2023. The analyses and visualizations were performed using VOSviewer software. Key metrics included annual publication trends, leading journals, citation analyses, keyword clusters, and collaboration networks among authors and institutions. Results: A total of 3,145 articles were analyzed. Publication volumes demonstrated a steady increase from 2004 to 2022, followed by a slight decline in 2023. The most prolific journals were Antibiotics Basel and the Journal of Antimicrobial Chemotherapy. Major themes included antimicrobial resistance, Escherichia coli, and infection control. The centers for disease control and prevention (CDC) and Johns Hopkins University were the leading contributors in this field. Collaboration networks highlighted strong international ties, particularly among institutions in the United States and Europe. Conclusion: Bibliometric trends underscore the increasing academic focus on UTIs, particularly regarding antibiotic stewardship and resistance. However, significant knowledge gaps persist in the prevention and management of UTIs, especially in hospital settings. Future research should prioritize multidisciplinary approaches and strengthen international collaborations to address these gaps effectively.

29 October 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
MUMustafa Usanmaz
Mustafa Usanmaz
SGSelim Görgün
Selim Görgün
MOMetin Ocak
Metin Ocak
MYMetin Yadigaroglu
Metin Yadigaroglu
MKMeltem Karslıoğlu
Meltem Karslıoğlu
ÖGÖzgür Günal
Özgür Günal
Background/Objectives: Sepsis remains a major cause of morbidity and mortality, and reliable diagnostic and prognostic biomarkers are needed. This study investigated the diagnostic and prognostic associations of endothelial cell-specific molecule-1 (ESM1), toll-like receptor (TLR)2, TLR4, and the TLR2/TLR4 ratio in sepsis. Methods: In this single-center prospective observational study, serum biomarker levels were measured in 60 patients with sepsis and 23 ambulatory controls and analyzed for associations with the presence of sepsis and in-hospital mortality. Demographic characteristics and comorbidities were comparable between groups. Results: No significant differences were observed in ESM1, TLR4, or the TLR2/TLR4 ratio between groups (p > 0.05). TLR2 levels were lower in patients with sepsis than in controls (median [IQR]: 0.551 [1.508] vs. 1.394 [8.606], respectively; p = 0.056), without reaching statistical significance. Receiver operating characteristic analysis yielded an AUC of 0.636 (p = 0.080) for TLR2, with 91.7% sensitivity and 47.8% specificity at a cut-off of ≤3.2129. In-hospital mortality occurred in 36.7% of patients. Serum creatinine levels were higher in non-survivors than survivors (median: 2.30 vs. 0.89 mg/dL; p = 0.039), whereas no significant associations with mortality were observed for demographic characteristics, clinical findings, other laboratory parameters, or biomarker levels. Conclusions: TLR2 levels were numerically lower in sepsis, but the difference was not statistically significant. Its diagnostic utility requires validation against non-infectious systemic inflammation in clinically relevant control populations. No significant diagnostic or prognostic associations were detected for ESM1, TLR4, or the TLR2/TLR4 ratio in this cohort.

24 September 2026 in Viruses
Verified
Journal Article
Open access
PDF file
MUMustafa Usanmaz
Mustafa Usanmaz
ÖGÖzgür Günal
Özgür Günal
BÖBurcu Özdemir
Burcu Özdemir
EAEsra Arslan Aksu
Esra Arslan Aksu
SGSavaş Gegin
Savaş Gegin
LOLevent Ozdemir
Levent Ozdemir
Pandemic non-pharmaceutical interventions disrupted seasonal respiratory virus circulation, but longer-term pathogen-specific patterns in hospitalized adults remain incompletely defined. We evaluated detections across three nonconsecutive respiratory seasons from early relaxation of pandemic measures to five years after pandemic onset. This retrospective, observational, single-center cohort study included 2249 adults hospitalized with pneumonia, chronic obstructive pulmonary disease exacerbation, or asthma exacerbation who underwent multiplex polymerase chain reaction testing in September 2021–May 2022, September 2022–May 2023, or September 2025–May 2026. Influenza A positivity peaked in the second period (12.6%) and decreased to 6.8% in the third (p < 0.001). SARS-CoV-2 likewise peaked in the second period (9.2%) and declined to 1.5% in the third (p < 0.001). Respiratory syncytial virus increased from 0.5% in the first period to 4.9% and 3.8% in the second and third periods, respectively (p < 0.001). Positivity for other respiratory viruses did not differ (16.0%, 16.9%, and 19.1%; p = 0.308). Viral co-detection was highest in the second period (6.1% vs. 2.6% and 2.8%; p < 0.001). Respiratory virus epidemiology remained dynamic five years after pandemic onset, supporting sustained multi-pathogen surveillance.